ITGB2-AS1
gene geneOn this page
Summary
ITGB2-AS1 (ITGB2 antisense RNA 1, HGNC:44304) is a long non-coding RNA gene on chromosome 21q22.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44304 |
| Approved symbol | ITGB2-AS1 |
| Name | ITGB2 antisense RNA 1 |
| Location | 21q22.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000227039 |
| Ensembl biotype | lncRNA |
| Entrez | 100505746 |
| RNAcentral | URS000075A18C — lncRNA, 2425 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 lncRNA
ENST00000429132, ENST00000441379, ENST00000608043, ENST00000609592, ENST00000609694, ENST00000610063, ENST00000688945, ENST00000692198, ENST00000798960, ENST00000798961, ENST00000832784
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000429132 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001598901 | 44927854 | 44928028 |
| ENSE00001617442 | 44926868 | 44927004 |
| ENSE00001640376 | 44921326 | 44921351 |
Expression profiles
Bgee: expression breadth ubiquitous, 206 present calls, max score 98.07.
FANTOM5 (CAGE): breadth broad, TPM avg 5.2287 / max 193.3725, expressed in 618 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 189509 | 1.6670 | 405 |
| 189506 | 1.1053 | 224 |
| 189511 | 0.9820 | 168 |
| 189512 | 0.9373 | 227 |
| 189510 | 0.3976 | 198 |
| 189508 | 0.0802 | 23 |
| 189507 | 0.0592 | 28 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 98.07 | gold quality |
| blood | UBERON:0000178 | 95.15 | gold quality |
| thymus | UBERON:0002370 | 94.65 | gold quality |
| monocyte | CL:0000576 | 92.94 | gold quality |
| leukocyte | CL:0000738 | 92.47 | gold quality |
| spleen | UBERON:0002106 | 92.29 | gold quality |
| lymph node | UBERON:0000029 | 92.04 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 90.07 | gold quality |
| bone marrow | UBERON:0002371 | 89.12 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 89.02 | gold quality |
| vermiform appendix | UBERON:0001154 | 88.56 | gold quality |
| pancreatic ductal cell | CL:0002079 | 87.35 | silver quality |
| ileal mucosa | UBERON:0000331 | 86.41 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 85.83 | silver quality |
| tonsil | UBERON:0002372 | 84.59 | gold quality |
| caecum | UBERON:0001153 | 84.45 | gold quality |
| bone marrow cell | CL:0002092 | 83.41 | gold quality |
| superficial temporal artery | UBERON:0001614 | 83.31 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 81.52 | silver quality |
| palpebral conjunctiva | UBERON:0001812 | 79.73 | gold quality |
| tibia | UBERON:0000979 | 79.33 | gold quality |
| buccal mucosa cell | CL:0002336 | 77.61 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 77.20 | gold quality |
| upper arm skin | UBERON:0004263 | 77.09 | gold quality |
| kidney epithelium | UBERON:0004819 | 76.58 | gold quality |
| gall bladder | UBERON:0002110 | 76.27 | gold quality |
| parietal pleura | UBERON:0002400 | 75.56 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 75.30 | gold quality |
| upper lobe of lung | UBERON:0008948 | 74.52 | gold quality |
| superior surface of tongue | UBERON:0007371 | 74.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.14 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 7)
- LncRNA ITGB2-AS1 could promote the migration and invasion of breast cancer cells by up-regulating ITGB2. (PMID:29941860)
- study suggested that ITGB2-AS1 played critical roles in the development and progression of osteosarcoma via Wnt/beta-catenin signalling, indicating that ITGB2-AS1 might be a valuable diagnostic biomarker and potential anticancer therapeutic target for osteosarcoma. (PMID:30260245)
- Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. (PMID:32165090)
- LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis. (PMID:34170494)
- [Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia]. (PMID:34627422)
- The expression and significance of long non-coding RNA ITGB2-AS1 in renal clear cell carcinoma. (PMID:36634939)
- LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis. (PMID:37370246)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.